Abstract:BACKGROUND: Retinoids modulate the growth and number of different cell types, including B cells. We could previously show that retinoic acid (RA) strongly inhibits CD40 + IL-4-mediated IgE production in vitro. The aim of the present study was to extend these findings regarding the potential use of retinoids for the treatment of allergic diseases.METHODS: In vitro IgE production was studied in anti-CD40 + IL-4-stimulated peripheral blood mononuclear cells (PBMC) from allergic donors in the presence of 10(-15)-10(-5) M all-trans and 13-cis RA and in ovalbumin (OVA)-sensitized BALB/c mice treated with RA (20 mg/kg) before and during sensitization. IgE and IgG1 levels were determined in the sera of the mice at day 21 after 2 injections (days 1 and 8) of aluminum hydroxide-absorbed OVA.RESULTS: All-trans and 13-cis RA inhibited in vitro IgE production from PBMC in a dose-dependent manner, but were more efficient in atopic dermatitis patients with low total serum IgE levels (< 400 kU/ml), maximal inhibition for all-trans RA at 10(-7) M (87%) and for 13-cis RA at 10(-5) M (96%) compared to patients with high serum IgE levels (>2,000 kU/ml), maximal inhibition for both all-trans and 13-cis RA at 10(-5) M (53 and 39%, respectively). In contrast, the in vivo data from OVA-sensitized mice revealed comparable total IgE and IgG1 levels in control versus all-trans RA or CD336-treated groups, specific IgE was even higher in the CD336-treated group (n = 10, 2,814 ng/ml), and was comparable in mice treated with OVA alone or with additional all-trans RA (n = 10, 1,447 and 1,354 ng/ml, respectively).CONCLUSIONS: These results indicate that the efficacy of retinoids to inhibit IgE production in vitro depends on the frequency of switched cells in the peripheral blood and that in an in vivo model using OVA-sensitized mice, retinoids fail to inhibit IgE production.

Retinoic Acid and Α-Galactosylceramide Differentially Regulate B Cell Activation in Vitro and Augment Antibody Production in Vivo

α-Galactosylceramide and all trans-retinoic acid work together to promote antigen presentation and antibody production

α-Galatosylceramide and retinoic acid regulate splenic follicular B cell differentiation and antibody production in a CD1d-dependent manner

Retinoic Acid and Α-Galactosylceramide Regulate the Expression of Costimulatory Receptors and Transcription Factors Responsible for B Cell Activation and Differentiation.

Retinoic Acid Regulates Α-Galactosylceramide-mediated B Cell Activation and Differentiation in CD19hi and CD19lo B Cell Subsets (42.9)

Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4

All-trans-retinoic acid and CD38 ligation differentially regulate CD1d expression and α-galactosylceramide-induced immune responses

Retinoic Acid Regulates Mouse B‐cell Activation and Differentiation Induced by Engagement of CD40, B‐cell Antigen Receptor and Cytokine IL‐4

Vitamin A and Retinoic Acid in the Regulation of B-Cell Development and Antibody Production

Augmentation of Antibody Responses by Retinoic Acid and Costimulatory Molecules

Retinoic Acid Regulates CD1d Gene Expression at the Transcriptional Level in Human and Rodent Monocytic Cells.

α-Galactosylceramide stimulates splenic lymphocyte proliferation in vitro and increases antibody production in vivo in late neonatal-age mice.

α-Galactosylceramide stimulates splenic lymphocyte proliferation in vitro and increases antibody production in vivo in the late neonatal-age mouse. (VAC12P.1028)

The effects of all-trans retinoic acid on immune cells and its formulation design for vaccines

All-trans-retinoic Acid and Erk1/2 Signaling Synergistically Regulate the Expression of CD300B in Human Monocytic Cells

Possible Role of Β-Galactosidase in Rheumatoid Arthritis

All-trans-retinoic Acid and the Glycolipid Α-Galactosylceramide Combined Reduce Breast Tumor Growth and Lung Metastasis in a 4T1 Murine Breast Tumor Model.

Effects of Retinoids on in vitro and in vivo IgE Production

High Doses of Α-Galactosylceramide Potentiate Experimental Autoimmune Encephalomyelitis by Directly Enhancing Th17 Response

Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response

The Bile Acid-Activated Retinoic Acid Response in Dendritic Cells is Involved in Food Allergen Sensitization.